Click here to go to the previous page
Wrangling the Bestiary of Safety Documents: Coordination and Integration across Multiple Requirements
Program Code:
131
Date:
Monday, June 25, 2012
Time:
1:30 PM to 3:00 PM
EST
CHAIR
:
Aaron Van Etten has >20 years experience as a medical writer and manager of medical writers at 3 companies and as a freelance writer, contributing to marketing applications for biologics & small molecules in diverse therapeutic areas (oncology, nephrology, osteoporosis, ophthalmology, inflammation).
|
PRESENTER
(S):
Sandy manages clinical trial & marketing applications, and safety reporting for drugs & biologics. Her experience: an IRB, starting Medical Writing at Genentech in 1990 & clin/reg management roles at CROs. Sandy represents clients to FDA and Health Canada, w team members for other regions.
|
Jan Sechler, Janssen Research & Development, LLC, United States
Michael D. Hoffman is Senior Director of Regulatory Medical Writing at United BioSource Corporation. He has over 20 years experience in pharmaceutical regulatory writing spanning early development through post-marketing surveillance.
|
Description
Medical writers' approaches to authoring pre- and postmarketing safety documents will be discussed with emphasis on meeting multiple, international requirements for products at various stages of development.
Learning Objectives:
Identify medical writers' strategies for authoring safety documents (eg, IB, DSUR, PIP, RMP, REMS, PV reports) with overlapping content
Identify different approaches to integrating multiple, international requirements for safety documents for products at various stages of development.